3 Surprising Ways Intel Is Merging Technology With Healthcare

Let’s look at three remarkable ways Intel is expanding into the healthcare industry.

Sep 1, 2014 at 3:03PM

Intel (NASDAQ:INTC) is generally known for its x86 microprocessors, which are closely tied to the fluctuations of the PC industry. Most investors generally don't think of the tech giant as a healthcare company. Yet Intel has recently made some interesting investments in wearable devices and mobile health -- two markets that are growing much faster than personal computers.


Source: Flickr.

According to Business Insider, the value of the wearables market is expected to grow from $5.2 billion this year to $12.6 billion by 2018. The mobile health market, which includes fitness apps and wearables, is expected to be worth $21.5 billion by 2018, according to BCC Research. By comparison, IDC expects annual desktop PC shipments -- Intel's core market -- to fall 6% between 2014 and 2017.

Therefore, it makes sense for Intel to diversify into healthcare to find new sources of growth. Let's look at three surprising ways Intel is merging its technology into wearable and mobile devices.

Biometric headphones
Intel recently announced a partnership with SMS Audio, which is majority-owned by rapper 50 Cent, to develop BioSport biometric earbuds.

The sweat and water-resistant earbuds will use an optical sensor for continuous heart rate monitoring, and synchronize with the RunKeeper app to track distance traveled and calories burned. Like fitness bands, the earbuds will synchronize to a chart showing a user's activity levels throughout the workout.


SMS Audio's BioSport earbuds. Source: Company website.

The biometric headphones will likely use technology gained from Intel's acquisition of activity tracker maker Basis in March. Basis' fitness bands use optical and skin sensors to take biometric readings.

Intel and SMS Audio aren't the only companies working on biometric earbuds. LG Electronics announced a similar product at the Consumer Electronics Show in January, and Apple (NASDAQ:AAPL) was granted a patent for biometric earbuds in March.

Although biometric earbuds have a narrower appeal than all-day fitness bands, demand for premium headphones remains high. High-end headphones maker Beats Electronics -- which was co-founded by Dr. Dre and recently acquired by Apple -- saw its annual revenue quintuple between 2010 and 2012.

Much tinier chips
The BioSport earbuds highlight another aspect of Intel's wearables strategy -- tiny chips designed to connect to the "Internet of Things."

During CES, Intel unveiled a tiny SD card-sized computer called Edison. Edison is a full-featured 400-megahertz computer equipped with Wi-Fi, Bluetooth, and other features. Intel demonstrated that Edison could be placed anywhere -- in chairs, appliances, coffee cups, or baby monitors -- to connect them to the Internet, apps, and each other.


Intel's Edison. Source: Intel.

Rest Devices' Mimo Baby Monitor -- which consists of a water-resistant turtle (which houses Edison) attached to a baby-sized "kimono" -- can wirelessly monitor a baby's breathing, temperature, and movements and transmit them to a companion app for iOS and Android. If the Mimo Baby Monitor is scaled up for adult patients, it could connect them to the wireless grids of "smart hospitals" for continuous monitoring.

Wearable devices in clinical trials
In mid-August, Intel announced a partnership with the Michael J. Fox Foundation in a wearables study for Parkinson's disease.

Since Parkinson's is characterized by slowed movement, tremors, balance issues, and poor sleep quality, there has been rising interest in using motion sensors and accelerometers -- two standard features in smartphones -- to detect the disease.

Over the past three years, apps such as Digital Arts' Tremor-Meter have arrived on mobile devices to detect tiny tremors in a patient's hand. Other apps can detect and correct slurred speech. Intel didn't disclose which wearables and mobile devices would be used during the Parkinson's study, but it will likely use similar methods.

Since the FDA recently approved several wearable devices for clinical trials, Intel's new presence in biometric sensors and tiny computers could help grow its footprint in healthcare through clinical trials as well.

The Foolish takeaway
Intel has a few fascinating opportunities to expand into the healthcare market.

If demand for fitness trackers merges with demand for premium headphones, the BioSport headphones could become the Fitbit of the audio world. If hospitals and medical device companies come up with creative uses for Edison, it could become a valuable tool as the Internet of Things expands. That could lead to the increased use of Intel technology in clinical trials for neurological disorders such as Parkinson's and Alzheimer's disease.

However, investors should note that Intel's rival ARM Holdings also has plans to expand into wearable devices and healthcare -- which could make this the next big battleground to watch for the two companies.

Leaked: Apple's next smart device (warning, it may shock you)
Apple recently recruited a secret-development "dream team" to guarantee its newest smart device was kept hidden from the public for as long as possible. But the secret is out, and some early viewers are claiming its everyday impact could trump the iPod, iPhone, and the iPad. In fact, ABI Research predicts 485 million of this type of device will be sold per year. But one small company makes Apple's gadget possible. And its stock price has nearly unlimited room to run for early in-the-know investors. To be one of them, and see Apple's newest smart gizmo, just click here!

Leo Sun owns shares of Apple. The Motley Fool recommends Apple and Intel. The Motley Fool owns shares of Apple and Intel. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information